Presentation TCT 2016 TCT 63: Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction Presenter: Julinda Mehilli, Georgios Sianos, Philippe Généreux October 31, 2016
Presentation TCT 2016 TCT 317: Ten-Year Impact of Stent Fracture and Peri-Stent Contrast staining After Sirolimus-Eluting Stent Implantation on Target Lesion Revascularization Presenter: Nicolas Foin, Giampaolo Niccoli October 31, 2016
Presentation TCT 2016 TCT 515: Prognostic Implications of Instantaneous Wave-Free Ratio (iFR) and Resting Distal-to-Aortic Pressure Ratio (Pd/Pa) Compared with Fractional Flow Reserve (FFR). A 10-Year Follow-Up Study After Deferral of Revascularization Presenter: Michalis Hamilos, Pim A.L. Tonino October 30, 2016
Presentation TCT 2016 TCT 140: Explore Trial (Additional Early CTO PCI in STEMI Patients with a Concurrent CTO) and SYNTAX score. What are Lessons Learned? Presenter: Warren J. Cantor, Thomas D. Stuckey October 30, 2016
Presentation TCT 2016 Mortality of Stenting vs Bypass Surgery According to Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of SYNTAX, PRECOMBAT, and BEST Trials Presenter: Jung-Min Ahn October 30, 2016
Presentation TCT 2016 TCT 139: A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients with Acute ST Elevation Myocardial Infarction and Multi Vessel Disease Presenter: Warren J. Cantor, Thomas D. Stuckey October 30, 2016
Presentation TCT 2016 TCT 138: Multivessel Versus Culprit-Only Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: Analysis of a 8 Year-All-Comers Registry Presenter: Warren J. Cantor, Thomas D. Stuckey October 30, 2016
Presentation TCT 2016 TCT 137: Influence of Nonculprit Lesions Management on Outcomes in Patients Over 75 Years Old With ST Elevated Myocardial Infarction. Results From the ESTROFA MI+75 Nationwide Registry Presenter: Warren J. Cantor, Thomas D. Stuckey October 30, 2016
Presentation TCT 2016 Medical Therapy, Revascularization, and CRT for Functional Mitral Regurgitation: Despite Class I Guidelines, Are the Benefits Substantial? Presenter: Ted Feldman, Allan Schwartz, JoAnn Lindenfeld October 30, 2016
Presentation TEACH 2016 The Role of Hemodynamic Support Devices in Complex Patients and Complete Revascularization Presenter: Daniel Burkhoff October 29, 2016
Presentation Stanford Coronary Physiology Conference 2016 FFR-Guided PCI Vs Medical Therapy: FAME 2 and Substudies Presenter: Bernard De Bruyne October 28, 2016
Presentation Stanford Coronary Physiology Conference 2016 Index of Microcirculatory Resistance: Derivation, Validation and Practical Aspects Presenter: William F. Fearon October 28, 2016
Presentation Long-term Mortality After Revascularization in Nondiabetic Patients With Multivessel Disease Presenter: Mineok Chang June 28, 2016
Presentation TVT 2016 Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (Indications for CABG vs PCI, Hybrid Approaches, and Completeness of Revascularization) Presenter: James B. Hermiller Jr June 17, 2016
Presentation CCVVC 2016 Global Perspective on Cardiovascular Health Presenter: Salim Yusuf June 16, 2016
Presentation CCVVC 2016 CTO Intervention: Current Indications and Results Presenter: Paul S. Teirstein June 16, 2016
Presentation CCVVC 2016 Plantar Loop Revascularization: My Way Presenter: Lanfroi Graziani June 15, 2016
Presentation CCVVC 2016 Explaining the discrepancy between low patency and higher limb salvage rates after revascularization for CLI: Does perfusion matter or not? Presenter: Marianne Brodmann June 15, 2016
Presentation SOLACI 2016 Complete Revascularization in Primary PCI Presenter: Neal S. Kleiman June 10, 2016
Presentation SOLACI 2016 The Role of Ischemia, Complete Revascularization and Intravascular Imaging in Contemporary PCI Presenter: Ajay J. Kirtane June 09, 2016